Oskar Smrzka
Technology
Affiris
Austria
Biography
Dr. Smrzka started his career at the Vienna Medical University followed by training as molecular biologist at the Research Institute of Molecular Pathology (Vienna IMP). After his PostDoc years in Amsterdam (The Netherlands Cancer Institute; epigenetics) and Paris (Institut Curie; cell biology), he joined the St. Anna Children’s Cancer Research Institute (CCRI, Vienna), addressing fundamental topics in molecular cell biology of rare childhood tumors. Entering biotech industry, he established a functional small molecule screening pipeline for a start-up biotech company at the Vienna Biocenter. At AFFiRiS, Dr. Oskar Smrzka’s Enabling Technologies group is currently focusing on preclinical validation and development of therapeutic active immunotherapies for Huntington’s disease and allergy.
Research Interest
Clinical sciences, Clinical trails, Clinical research
